Hydroxyurea Completed Phase 4 Trials for Sickle Cell Disease (SCD) / Renal Function Disorder Other

IndicationsStatusPurposePhase
CompletedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT02522104Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)